The kallikrein world: an update on the human tissue kallikreins (Q36519354)

14 August 2017

1 reference

title

The kallikrein world: an update on the human tissue kallikreins (English)

1 reference

14 August 2017

author

Eleftherios P. Diamandis

series ordinal

object named as

Eleftherios P Diamandis

1 reference

14 August 2017

Miltiadis Paliouras

1 reference

14 August 2017

publication date

1 June 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

387

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

643-652

1 reference

Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Enzymatic profiling of human kallikrein 14 using phage-display substrate technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

International Union of Pharmacology. XXVIII. Proteinase-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 13 involvement in extracellular matrix degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Complex formation between human kallikrein 13 and serum protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 10: a novel tumor marker for ovarian carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5' promoter region of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Determinants of rapamycin sensitivity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Cloning and characterization of novel isoforms of the human kallikrein 6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Nuclear receptors: integration of multiple signalling pathways through phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Quantitative analysis of kallikrein 15 gene expression in prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Increased expression of protease M in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Suicide gene therapy on LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

The new human tissue kallikrein gene family: structure, function, and association to disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Cloning of a kallikrein pseudogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2006.083

21 January 2018

Identifiers

DOI

10.1515/BC.2006.083

1 reference

14 August 2017

1 reference